Qiagen signals $2.38 adjusted EPS target and $500M share repurchase while advancing single-cell strategy
Source: SeekingAlpha
2025-11-05 15:51:57 ET
More on Qiagen
- Qiagen N.V. (QGEN) Q3 2025 Earnings Call Transcript
- Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript
- Qiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 Transcript
- Qiagen Non-GAAP EPS of $0.61 beats by $0.02, revenue of $533M beats by $7.09M
- Qiagen Q3 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Qiagen signals $2.38 adjusted EPS target and $500M share repurchase while advancing single-cell strategy
Qiagen N.V.
NASDAQ: QGEN
QGEN Trading
-3.03% G/L:
$41.90 Last:
1,050,835 Volume:
$42.64 Open:
QGEN Latest News
March 10, 2026 05:05:00 pm
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
QGEN Stock Data
$10,633,318,293
203,932,295
N/A
22
N/A
Biotechnology & Life Sciences
Healthcare
NL
Venlo
